Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Shareholders held by Ginkgo Bioworks Holdings, Inc. on June 12, 2025. The filing details the voting results for director elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events and does not contain financial performance data.
Material Changes and Voting Results
Shareholder participation was significant, with approximately 78.27% of Class A and Class B shares (voting as a single class) and 91.07% of Class B shares (voting separately) present or represented by proxy. All three proposals presented were approved:
- Election of Directors: Seven nominees were elected. Two nominees (Jason Kelly and Reshma Shetty) were elected by Class B shareholders voting separately. Five nominees (Ross Fubini, Christian Henry, Sri Kosuri, Shyam Sankar, and Harry E. Sloan) were elected by Class A and Class B shareholders voting together.
- Auditor Ratification: Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Executive Compensation: The advisory vote to approve named executive officer compensation was approved.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the procedural results of the shareholder meeting.
Key Facts for Investor Verification
- Verify the specific vote counts for director nominees, noting that Christian Henry, Shyam Sankar, and Harry E. Sloan received higher "Against" votes compared to other Class A/B nominees.
- Confirm the dual-class voting structure where Class B shares carry ten votes per share versus one vote per share for Class A.
- Review the full proxy statement for details on the executive compensation package approved in Proposal three.
- Check subsequent filings for the financial results of the fiscal year ending December 31, 2025, as this 8-K does not contain financial data.